LINC02121

Across TCGA pan-cancer cohorts, LINC02121 RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated LINC02121 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher LINC02121 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC02121 expression acts as an unfavorable survival marker, although some lineages such as KIRC and BLCA show a favorable association.

LUAD, SKCM, and KIRC are the cancer types where LINC02121 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Tertile	II,III,IV	0.111	0.750	<.001	72	view →
SKCM	OS	Median	II,III,IV	0.214	0.366	.005	16	view →
KIRC	DFS	Tertile	All	0.703	0.603	.019	15	view →
BLCA	OS	Tertile	All	0.901	0.423	.035	12	view →
GBM	DFS	Tertile	All	0.074	0.292	.046	9	view →
LIHC	DFS	Tertile	II,III,IV	0.772	0.313	.049	3	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

LINC02121–LUAD (OS)

Open the LUAD breakdown →